DEPACON vs STAVZOR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. DEPACON and STAVZOR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DEPACON	STAVZOR
Rating	72/100	70/100
Pharmacy pays	—	~$1.02 /30
Type	RX	RX
Active ingredient	VALPROATE SODIUM	VALPROIC ACID
Manufacturer	Abbvie	Bionpharma
Dosage forms	Injectable	Capsule, delayed release
Drug class	Anti-Epileptic Agent	Anti-Epileptic Agent
Boxed warning	None	None
Half-life	about 9 to 16 hours (the label's mean terminal, or elimination, half-life for valproate monotherapy after oral doses of 250 to 1,000 mg)	—
Treats	—	Alzheimer Disease, Bipolar Disorder, Epilepsy

depacon stavzor

Rating

72/100

70/100

Pharmacy pays

—

~$1.02 /30

Type

Active ingredient

VALPROATE SODIUM

VALPROIC ACID

Manufacturer

Abbvie

Bionpharma

Dosage forms

Injectable

Capsule, delayed release

Drug class

Anti-Epileptic Agent

Boxed warning

None

Half-life

about 9 to 16 hours (the label's mean terminal, or elimination, half-life for valproate monotherapy after oral doses of 250 to 1,000 mg)

—

Treats

—

Alzheimer Disease, Bipolar Disorder, Epilepsy

Frequently asked questions

Which is better-rated, Depacon or Stavzor?

By our independent rating, Depacon scores higher — 3.6 vs 3.5 out of 5 for Stavzor. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Depacon and Stavzor?

Depacon contains Valproate Sodium, while Stavzor contains Valproic Acid — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.